Anonymous
Guest
Anonymous
Guest
I didn't write this, but it is so accurate!
Don't blame the Sales side. The RBD's, though, never stood up to anything, I will say that about them. They watched the poor clinical provisions by the MSL team and the poor marketing campaign by the stooges, who if you looked at their resume's would prove how poorly qualified they are
Ask yourself where are the deliverable's? Ipsen where are they? French Ipsen where are they?
Clinical - No MSL contact in the field without pulling teeth
Clinical Training - No clinical training at all for the providers on injection with a different product
Advisory Boards - Barely any activity in this area of provider development. The big thought leaders feel that Ipsen and the organization have just walked away from partnership
VIP Visits - NONE, So how important Ipsen is it for you to make a presence in this market place. No one knows because Ipsen has no identity in the market place
Marketing - No Silver Bullet he said, well how about a copper BB, can you at least develop that?
Coverage - This is the one area where things have gone well. Probably by accident as we were the monopoly buster. Providers are getting paid and even sometimes more than btx
CSS's - They want us to just show up and convince our providers with a smile and a new toxin to use it. Sure that has always worked in the pharma/bio industry. Why should anyone trust us just on a message of "here it is" Oh and thanks for those that did perform well, you doubled or tripled our quota's Hey Frenchy, the whole USA has your turn and burn mentality figured out. Why do you think people have turned down offers to take less to go elsewhere? The top performers are looking to get out also, so once they leave then maybe you will realize ..........."The French Emperor is wearing no Clothes"
Reply With Quote
Don't blame the Sales side. The RBD's, though, never stood up to anything, I will say that about them. They watched the poor clinical provisions by the MSL team and the poor marketing campaign by the stooges, who if you looked at their resume's would prove how poorly qualified they are
Ask yourself where are the deliverable's? Ipsen where are they? French Ipsen where are they?
Clinical - No MSL contact in the field without pulling teeth
Clinical Training - No clinical training at all for the providers on injection with a different product
Advisory Boards - Barely any activity in this area of provider development. The big thought leaders feel that Ipsen and the organization have just walked away from partnership
VIP Visits - NONE, So how important Ipsen is it for you to make a presence in this market place. No one knows because Ipsen has no identity in the market place
Marketing - No Silver Bullet he said, well how about a copper BB, can you at least develop that?
Coverage - This is the one area where things have gone well. Probably by accident as we were the monopoly buster. Providers are getting paid and even sometimes more than btx
CSS's - They want us to just show up and convince our providers with a smile and a new toxin to use it. Sure that has always worked in the pharma/bio industry. Why should anyone trust us just on a message of "here it is" Oh and thanks for those that did perform well, you doubled or tripled our quota's Hey Frenchy, the whole USA has your turn and burn mentality figured out. Why do you think people have turned down offers to take less to go elsewhere? The top performers are looking to get out also, so once they leave then maybe you will realize ..........."The French Emperor is wearing no Clothes"
Reply With Quote